Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin
- PMID: 41398426
- PMCID: PMC12705672
- DOI: 10.1038/s41598-025-31415-1
Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin
Retraction of
-
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.Sci Rep. 2017 Aug 29;7(1):9749. doi: 10.1038/s41598-017-10325-x. Sci Rep. 2017. Retraction in: Sci Rep. 2025 Dec 15;15(1):43808. doi: 10.1038/s41598-025-31415-1. PMID: 28852098 Free PMC article. Retracted.
References
Publication types
LinkOut - more resources
Full Text Sources
